S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
Log in
OTCMKTS:VODG

Vitro Diagnostics Stock Forecast, Price & News

$0.40
0.00 (0.00 %)
(As of 10/15/2020)
Add
Compare
Today's Range
$0.40
Now: $0.40
$0.40
50-Day Range
$0.40
MA: $0.40
$0.40
52-Week Range
$0.13
Now: $0.40
$1.04
VolumeN/A
Average VolumeN/A
Market Capitalization$18.52 million
P/E RatioN/A
Dividend YieldN/A
Beta2.08
Vitro Diagnostics, Inc., doing business as Vitro Biopharma, focuses on the development, manufacture, and distribution of stem cell products and related tools for use in research, drug discovery, and clinical trials in the United States. Its stem cell technology includes cell lines, supporting products, and methods for generation and differentiation of stem cells into products for the treatment of diseases, such as heart disease, arthritis, multiple sclerosis, brain injury, autism, stroke, Parkinson's, and Alzheimer's diseases. The company also offers Tools for Stem Cell and Drug Discovery that provide researchers basic tools needed to advance stem cell technology, including stem cells and their derivatives; media for growth and differentiation of stem cells; and tools for measurement of stem cell quality, potency, and response to toxic agents. In addition, it offers MSC-Gro, a cell culture media product; MSC cell line for the treatment of skeletal muscular conditions, such as tendonitis, ligament injury, osteoarthritis and accelerated bone fracture healing, etc.; and testing and therapies related to endogenous stem cell activation. Further, the company provides diagnostic testing of stem cell activation and determination of stem cell functional status; and cell-based assays for discovery of novel stem cell activation agents and drugs for the treatment of osteoporosis. Vitro Diagnostics, Inc. was founded in 1986 and is based in Golden, Colorado.

MarketRank

Overall MarketRank

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:VODG
CUSIPN/A
Phone303-999-2130
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$18.52 million
Next Earnings DateN/A
OptionableNot Optionable
$0.40
0.00 (0.00 %)
(As of 10/15/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive VODG News and Ratings via Email

Sign-up to receive the latest news and ratings for VODG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Vitro Diagnostics (OTCMKTS:VODG) Frequently Asked Questions

How has Vitro Diagnostics' stock been impacted by Coronavirus?

Vitro Diagnostics' stock was trading at $0.2250 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, VODG stock has increased by 77.8% and is now trading at $0.40.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Vitro Diagnostics?

Wall Street analysts have given Vitro Diagnostics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Vitro Diagnostics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Vitro Diagnostics' key competitors?

What other stocks do shareholders of Vitro Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vitro Diagnostics investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), (PCSA), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), (HGEN) and Kaleido Biosciences (KLDO).

Who are Vitro Diagnostics' key executives?

Vitro Diagnostics' management team includes the following people:
  • Dr. James R. Musick, Chairman, CEO & Pres (Age 73)
  • Mr. John R. Evans, CFO & Director (Age 65)
  • Mr. Keith V. Burge, Sr. Director of Sales & Marketing

What is Vitro Diagnostics' stock symbol?

Vitro Diagnostics trades on the OTCMKTS under the ticker symbol "VODG."

How do I buy shares of Vitro Diagnostics?

Shares of VODG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vitro Diagnostics' stock price today?

One share of VODG stock can currently be purchased for approximately $0.40.

How big of a company is Vitro Diagnostics?

Vitro Diagnostics has a market capitalization of $18.52 million.

What is Vitro Diagnostics' official website?

The official website for Vitro Diagnostics is www.vitrobiopharma.com.

How can I contact Vitro Diagnostics?

Vitro Diagnostics' mailing address is 4621 Technology Drive, Golden CO, 80403. The company can be reached via phone at 303-999-2130 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.